The aim of this study is to explore whether the ST6Gal1, Neu1, ST3Gal1, and Neu3 levels in the B cells and monocytes of RA patients could be useful for determining RA disease activity improvement and remission. The gene discussed is ST6GAL1; the disease is rheumatoid arthritis.